BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 34728554)

  • 1. All-cause mortality in systemic rheumatic diseases under treatment compared with the general population, 2015-2019.
    Bournia VK; Fragoulis GE; Mitrou P; Mathioudakis K; Tsolakidis A; Konstantonis G; Vourli G; Paraskevis D; Tektonidou MG; Sfikakis PP
    RMD Open; 2021 Nov; 7(3):. PubMed ID: 34728554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost of illness in rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis and systemic lupus erythematosus in Germany.
    Huscher D; Merkesdal S; Thiele K; Zeidler H; Schneider M; Zink A;
    Ann Rheum Dis; 2006 Sep; 65(9):1175-83. PubMed ID: 16540552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different COVID-19 outcomes among systemic rheumatic diseases: a nation-wide cohort study.
    Bournia VK; Fragoulis GE; Mitrou P; Mathioudakis K; Tsolakidis A; Konstantonis G; Tseti I; Vourli G; Tektonidou MG; Paraskevis D; Sfikakis PP
    Rheumatology (Oxford); 2023 Mar; 62(3):1047-1056. PubMed ID: 35920774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health-related quality of life in systemic sclerosis compared with other rheumatic diseases: a cross-sectional study.
    Park EH; Strand V; Oh YJ; Song YW; Lee EB
    Arthritis Res Ther; 2019 Feb; 21(1):61. PubMed ID: 30770765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative analysis of anxiety-depressive spectrum disorders in patients with rheumatic diseases.
    Lisitsyna TA; Veltishchev DY; Seravina OF; Kovalevskaya OB; Starovoytova MN; Desinova OV; Abramkin AA; Ovcharov PS; Vasil'ev VI; Alekberova ZS; Krasnov VN; Nasonov EL
    Ter Arkh; 2018 May; 90(5):30-37. PubMed ID: 30701894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Employment across chronic inflammatory rheumatic diseases and comparison with the general population.
    Mau W; Listing J; Huscher D; Zeidler H; Zink A
    J Rheumatol; 2005 Apr; 32(4):721-8. PubMed ID: 15801031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased Prevalence of Systemic Lupus Erythematosus Comorbidity in Patients With Psoriatic Arthritis: A Population-based Case-control Study.
    Korkus D; Gazitt T; Cohen AD; Feldhamer I; Lavi I; Haddad A; Greenberg-Dotan S; Batat E; Zisman D
    J Rheumatol; 2021 Feb; 48(2):207-213. PubMed ID: 32414958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The comparative one-year performance of anti-tumor necrosis factor alpha drugs in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: results from a longitudinal, observational, multicenter study.
    Heiberg MS; Koldingsnes W; Mikkelsen K; Rødevand E; Kaufmann C; Mowinckel P; Kvien TK
    Arthritis Rheum; 2008 Feb; 59(2):234-40. PubMed ID: 18240258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased matrix metalloproteinase-3 serum levels in rheumatic diseases: relationship with synovitis and steroid treatment.
    Ribbens C; Martin y Porras M; Franchimont N; Kaiser MJ; Jaspar JM; Damas P; Houssiau FA; Malaise MG
    Ann Rheum Dis; 2002 Feb; 61(2):161-6. PubMed ID: 11796404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of hyaluronic acid in patients with rheumatoid arthritis, systemic sclerosis and systemic lupus erythematosus.
    Cylwik B; Gruszewska E; Gindzienska-Sieskiewicz E; Kowal-Bielecka O; Chrostek L
    Biochem Med (Zagreb); 2021 Jun; 31(2):020701. PubMed ID: 33927551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum COMP-C3b complexes in rheumatic diseases and relation to anti-TNF-α treatment.
    Happonen KE; Saxne T; Geborek P; Andersson M; Bengtsson AA; Hesselstrand R; Heinegård D; Blom AM
    Arthritis Res Ther; 2012 Jan; 14(1):R15. PubMed ID: 22264230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of genetics and epigenetics in rheumatic diseases: are they really a target to be aimed at?
    Kato M; Yasuda S; Atsumi T
    Rheumatol Int; 2018 Aug; 38(8):1333-1338. PubMed ID: 29623390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of prescription opioids among patients with rheumatic diseases compared to patients with hypertension in the USA: a retrospective cohort study.
    Chen SK; Feldman CH; Brill G; Lee YC; Desai RJ; Kim SC
    BMJ Open; 2019 Jun; 9(6):e027495. PubMed ID: 31221884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health-related quality of life and utility: comparison of ankylosing spondylitis, rheumatoid arthritis, and systemic lupus erythematosus patients in Taiwan.
    Chen HH; Chen DY; Chen YM; Lai KL
    Clin Rheumatol; 2017 Jan; 36(1):133-142. PubMed ID: 27837342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased Risk of Common Orthopedic Surgeries for Patients with Rheumatic Diseases in Taiwan.
    Hsieh MC; Koo M; Hsu CW; Lu MC
    Medicina (Kaunas); 2022 Nov; 58(11):. PubMed ID: 36422167
    [No Abstract]   [Full Text] [Related]  

  • 16. Atherosclerotic cardiovascular disease in hospitalized patients with systemic sclerosis: higher mortality than patients with lupus and rheumatoid arthritis.
    Dave AJ; Fiorentino D; Lingala B; Krishnan E; Chung L
    Arthritis Care Res (Hoboken); 2014 Feb; 66(2):323-7. PubMed ID: 24022876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Separating the effects of childhood and adult body size on inflammatory arthritis: a Mendelian randomisation study.
    Zhao SS; Bowes J; Barton A; Davey Smith G; Richardson T
    RMD Open; 2022 Aug; 8(2):. PubMed ID: 35995490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brief Report: Patterns and Secular Trends in Use of Immunomodulatory Agents During Pregnancy in Women With Rheumatic Conditions.
    Desai RJ; Huybrechts KF; Bateman BT; Hernandez-Diaz S; Mogun H; Gopalakrishnan C; Patorno E; Kim SC
    Arthritis Rheumatol; 2016 May; 68(5):1183-9. PubMed ID: 26606742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Health care and burden of illness in systemic lupus erythematosus compared to rheumatoid arthritis: results from the National Database of the German Collaborative Arthritis Centres.
    Zink A; Fischer-Betz R; Thiele K; Listing J; Huscher D; Gromnica-Ihle E; Specker C; Schneider M;
    Lupus; 2004; 13(7):529-36. PubMed ID: 15352425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Percutaneous coronary intervention outcomes in patients with rheumatoid arthritis, systemic lupus erythematosus and systemic sclerosis.
    Martinez SC; Mohamed M; Potts J; Abhishek A; Roddy E; Savage M; Bharadwaj A; Kwok CS; Bagur R; Mamas MA
    Rheumatology (Oxford); 2020 Sep; 59(9):2512-2522. PubMed ID: 31990337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.